Discover the top biotech companies pioneering the next healthcare breakthroughs. Learn how innovative firms are ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

To say that 2seventy bio’s short two years of existence have been dramatic is an understatement. CEO Chip Baird told BioSpace transparency and a committed staff have kept the biotech going through ...

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for ...

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...